Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Wearable Ultrasound Imaging System and Its Application in Intraoperative Cardiac Monitoring and Cardiopulmonary Monitoring in Critical Care

NCT07891052 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07891052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Wearable Ultrasound Imaging System and Its Application in Intraoperative Cardiac Monitoring and Cardiopulmonary Monitoring in Critical Care
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 1 arm.

  • Wearable Ultrasound Monitoring ExperimentalWearable Ultrasound Imaging System

    All participants will undergo cardiac monitoring using a wearable ultrasound imaging system in addition to conventional bedside echocardiography. Wearable ultrasound assessments will generally be performed hourly under stable clinical conditions and additionally when significant circulatory changes occur. Conventional bedside echocardiography will be performed daily for comparison. A subgroup of 400 participants will also undergo integrated monitoring combining wearable ultrasound with electrocardiography, blood pressure, and oxygen saturation measurements.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Agreement in Left Ventricular Ejection Fraction Measurements Day 1

    Agreement between left ventricular ejection fraction (LVEF) measurements obtained using wearable ultrasound and conventional bedside echocardiography will be assessed using the intraclass correlation coefficient (ICC). Paired measurements will be used to evaluate the consistency of the two methods.

Lead sponsor's other trials

China National Center for Cardiovascular Diseases, most recent start first.

Similar trials

Same condition (Cardiovascular Diseases) and phase, most recent start first.